Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Journal of the American Academy of Child and Adolescent Psychiatry
|
April 22, 2005
Atomoxetine and tics in ADHD
Peter D Feldman, Dustin D Ruff, Albert J Allen
American Journal of Men'S Health
|
January 29, 2016
A Pilot Study Using a Web Survey to Identify Characteristics That Influence Hypogonadal Men to Initiate Testosterone Replacement Therapy
Raymond C Rosen, Allen D Seftel, Dustin D Ruff, et al.
American Journal of Men'S Health
|
October 7, 2015
The Effect of Testosterone Topical Solution in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel
Patrick R Burns, Edward D Kim, Dustin D Ruff, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
January 24, 2007
CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD
David Michelson, Holly A Read, Dustin D Ruff, et al.
Pharmacoepidemiology and Drug Safety
|
October 8, 2024
Monitoring Pregnancies Exposed to Galcanezumab for Migraine in a United States Administrative Claims Database
Sarah R Hoffman, Francis Mawanda, Christopher L Crowe, et al.
The Journal of Clinical Psychiatry
|
January 18, 2014
Atomoxetine tolerability in pediatric and adult patients receiving different dosing strategies
Linda A Wietecha, Dustin D Ruff, Albert J Allen, et al.
Patient Preference and Adherence
|
December 7, 2018
Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine
Janet H Ford, Shonda A Foster, Virginia L Stauffer, et al.
Pediatrics
|
November 15, 2006
Low-dose atomoxetine for maintenance treatment of attention-deficit/hyperactivity disorder
Jeffrey H Newcorn, David Michelson, Christopher J Kratochvil, et al.
Clinical Therapeutics
|
March 22, 2014
Onset of response with duloxetine treatment in patients with osteoarthritis knee pain and chronic low back pain: a post hoc analysis of placebo-controlled trials
Owen D Williamson, Melissa Schroer, Dustin D Ruff, et al.
The American Journal of Psychiatry
|
February 19, 2008
Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response
Jeffrey H Newcorn, Christopher J Kratochvil, Albert J Allen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Journal of the American Academy of Child and Adolescent Psychiatry
|
April 22, 2005
Atomoxetine and tics in ADHD
Peter D Feldman, Dustin D Ruff, Albert J Allen
American Journal of Men'S Health
|
January 29, 2016
A Pilot Study Using a Web Survey to Identify Characteristics That Influence Hypogonadal Men to Initiate Testosterone Replacement Therapy
Raymond C Rosen, Allen D Seftel, Dustin D Ruff, et al.
American Journal of Men'S Health
|
October 7, 2015
The Effect of Testosterone Topical Solution in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel
Patrick R Burns, Edward D Kim, Dustin D Ruff, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
January 24, 2007
CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD
David Michelson, Holly A Read, Dustin D Ruff, et al.
Pharmacoepidemiology and Drug Safety
|
October 8, 2024
Monitoring Pregnancies Exposed to Galcanezumab for Migraine in a United States Administrative Claims Database
Sarah R Hoffman, Francis Mawanda, Christopher L Crowe, et al.
The Journal of Clinical Psychiatry
|
January 18, 2014
Atomoxetine tolerability in pediatric and adult patients receiving different dosing strategies
Linda A Wietecha, Dustin D Ruff, Albert J Allen, et al.
Patient Preference and Adherence
|
December 7, 2018
Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine
Janet H Ford, Shonda A Foster, Virginia L Stauffer, et al.
Pediatrics
|
November 15, 2006
Low-dose atomoxetine for maintenance treatment of attention-deficit/hyperactivity disorder
Jeffrey H Newcorn, David Michelson, Christopher J Kratochvil, et al.
Clinical Therapeutics
|
March 22, 2014
Onset of response with duloxetine treatment in patients with osteoarthritis knee pain and chronic low back pain: a post hoc analysis of placebo-controlled trials
Owen D Williamson, Melissa Schroer, Dustin D Ruff, et al.
The American Journal of Psychiatry
|
February 19, 2008
Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response
Jeffrey H Newcorn, Christopher J Kratochvil, Albert J Allen, et al.
Page
of 2